{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:09:56Z","timestamp":1778695796123,"version":"3.51.4"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), once known as Non-alcoholic fatty liver disease, impacts between 3% and 10% of children and adolescents globally, as well as nearly one-third of obsessed boys and one-quarter of obsessed girls, and is the most frequent cause of pediatric liver disease associated with the obesity epidemic. With the growing attention and increasing volume of literature on pediatric MASLD, there is an urgent need for bibliometric analysis and visualization in the area of pediatric MASLD study in terms of dissecting study priorities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Literature was searched in the Web of Science Core Collection database, followed by categorization, bibliometric study as well as visual analysis conducted by applying software including Citespace, VOSviewer, and the R language. The study concentrated on analyzing information related to key authors, spatial and temporal distribution, core keywords, and important citations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 3,409 publications on pediatric MASLD were collected in the study, including 2,697 articles and 712 review articles. Between 2004 and 2024, the volume of publications had been constantly increasing per year. The country with the most numerous publications was the United States, which had extensive exchanges and collaborations with Italy, China, and England, followed by Italy. The <jats:italic>Journal of Pediatric Gastroenterology and Nutrition<\/jats:italic> had the greatest quantity of publications in this domain. The core literature was a clinical guideline. Insulin resistance, metabolic syndrome, steatohepatitis, hepatocellular carcinoma, cardiovascular risk, diabetes risk, diagnostic accuracy, lifestyle intervention, gut microbiome, probiotics, and metabolic dysfunction-associated steatotic liver disease were also hot topics and frontier trends in pediatric MASLD studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This research represents the inaugural application of bibliometric analysis to examine the developmental trajectory of pediatric MASLD studies over the past two decades, which reveals that the etiology, pathological changes of the liver, relationship with obesity, complications, comorbidities, diagnosis and treatments of pediatric MASLD are the key focuses and provides academic references for pediatric clinicians and scholars to grasp the hotspots, the cutting edge and the evolving trends in the area.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1468788","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:29:58Z","timestamp":1745818198000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["A bibliometric analysis of metabolic dysfunction-associated steatotic liver disease in children from 2004 to 2024"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaowei","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enze","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"ITC65","DOI":"10.7326\/AITC201811060","article-title":"Nonalcoholic fatty liver disease","volume":"169","author":"Wang","year":"2018","journal-title":"Ann Intern Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/archdischild-2019-318063","article-title":"Non-alcoholic fatty liver disease and childhood obesity","volume":"106","author":"Shaunak","year":"2021","journal-title":"Arch Dis Child"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of nonalcoholic fatty liver disease in children with obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J Pediatr"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e934134","DOI":"10.12659\/MSM.934134","article-title":"A review of the increasing prevalence of metabolic-associated fatty liver disease (MAFLD) in children and adolescents worldwide and in Mexico and the implications for public health","volume":"27","author":"Ram\u00edrez-Mej\u00eda","year":"2021","journal-title":"Med Sci Monit"},{"key":"B7","doi-asserted-by":"publisher","first-page":"213737","DOI":"10.1155\/2015\/213737","article-title":"Association of nonalcoholic fatty liver disease with subclinical cardiovascular changes: a systematic review and meta-analysis","volume":"2015","author":"Bonci","year":"2015","journal-title":"Biomed Res Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000518595","article-title":"Nonalcoholic fatty liver disease in children with obesity: narrative review and research gaps","volume":"95","author":"Furthner","year":"2022","journal-title":"Horm Res Paediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/apt.17096","article-title":"Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000\u20132021","volume":"56","author":"Li","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/1094428114562629","article-title":"Bibliometric methods in management and organization","volume":"18","author":"Zupic","year":"2015","journal-title":"Organ Res Methods"},{"key":"B13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/520429a","article-title":"Bibliometrics: the Leiden manifesto for research metrics","volume":"520","author":"Hicks","year":"2015","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2147\/JPR.S409380","article-title":"Bibliometric analysis on GABA-A receptors research based on CiteSpace and VOSviewer","volume":"16","author":"Yu","year":"2023","journal-title":"J Pain Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.3748\/wjg.v29.i37.5339","article-title":"Global trends and hotspots of treatment for nonalcoholic fatty liver disease: a bibliometric and visualization analysis (2010\u20132023)","volume":"29","author":"Dai","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/MCO.0b013e328342baec","article-title":"Nonalcoholic fatty liver disease in children","volume":"14","author":"Mencin","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0216135","DOI":"10.1371\/journal.pone.0216135","article-title":"Worldwide research trends on aristolochic acids (1957\u20132017): suggestions for researchers","volume":"14","author":"Zhou","year":"2019","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1002\/edm2.460","article-title":"Emerging trends and hotspots in the links between the bile acids and NAFLD from 2002 to 2022: a bibliometric analysis","volume":"7","author":"Shibo","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1306234","DOI":"10.3389\/fped.2023.1306234","article-title":"Global research trends of mycoplasma pneumoniae pneumonia in children: a bibliometric analysis","volume":"11","author":"Song","year":"2023","journal-title":"Front Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0140908","DOI":"10.1371\/journal.pone.0140908","article-title":"The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis","volume":"10","author":"Anderson","year":"2015","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/MPG.0b013e318252a13f","article-title":"Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN hepatology committee","volume":"54","author":"Vajro","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"106786","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharmacol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.metabol.2016.01.008","article-title":"Similarities and differences between pediatric and adult nonalcoholic fatty liver disease","volume":"65","author":"Crespo","year":"2016","journal-title":"Metab Clin Exp"},{"key":"B31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/17474124.2019.1605290","article-title":"When a secondary form of pediatric non-alcoholic fatty liver disease should be suspected?","volume":"13","author":"Di Sessa","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"603654","DOI":"10.3389\/fped.2020.603654","article-title":"New perspectives on genetic prediction for pediatric metabolic associated fatty liver disease","volume":"8","author":"Lin","year":"2020","journal-title":"Front Pediatr"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/liv.14020","article-title":"Insights into paediatric non-alcoholic fatty liver disease from genetic variants","volume":"39","author":"Dong","year":"2019","journal-title":"Liver Int"},{"key":"B35","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/10408363.2019.1711360","article-title":"Fructose and hepatic insulin resistance","volume":"57","author":"Softic","year":"2020","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"key":"B37","doi-asserted-by":"publisher","first-page":"683743","DOI":"10.3389\/fcimb.2021.683743","article-title":"Gut microbiota, glucose, lipid, and water-electrolyte metabolism in children with nonalcoholic fatty liver disease","volume":"11","author":"Pan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.3748\/wjg.v24.i27.2974","article-title":"Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: from \u201ctwo hit theory\u201d to \u201cmultiple hit model\u201d","volume":"24","author":"Fang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/gut.2008.171280","article-title":"The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years","volume":"58","author":"Feldstein","year":"2009","journal-title":"Gut"},{"key":"B40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/children4070057","article-title":"The association between non-alcoholic fatty liver disease and cardiovascular risk in children","volume":"4","author":"Di Sessa","year":"2017","journal-title":"Children"},{"key":"B41","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J Hepatol"},{"key":"B42","first-page":"209","article-title":"Sirtuin 1, a diagnostic protein marker and its relevance to chronic disease and therapeutic drug interventions","volume":"6","author":"Martins","year":"2018","journal-title":"EC Pharmacol Toxicol"},{"key":"B43","first-page":"1","article-title":"Nutrition therapy regulates caffeine metabolism with relevance to NAFLD and induction of type 3 diabetes","volume":"4","author":"Martins","year":"2017","journal-title":"J Diabetes Metab Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21767\/2472-1158.100058","article-title":"Single gene inactivation with implications to diabetes and multiple organ dysfunction syndrome","volume":"3","author":"Martins","year":"2017","journal-title":"J Clin Epigenet"},{"key":"B45","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.3748\/wjg.v22.i32.7236","article-title":"Transient elastography (FibroScan(\u00ae)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease\u2014where do we stand?","volume":"22","author":"Mikolasevic","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/hep.29241","article-title":"Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease","volume":"66","author":"Schwimmer","year":"2017","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11894-015-0447-z","article-title":"A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic fatty liver disease","volume":"17","author":"Mansoor","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"418","DOI":"10.17235\/reed.2022.8796\/2022","article-title":"Probiotics and non-alcoholic fatty liver disease in children and adolescents: a systematic review","volume":"115","author":"Avelar-Rodr\u00edguez","year":"2023","journal-title":"Rev Esp Enferm Dig"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4829","DOI":"10.3390\/nu15224829","article-title":"Dietary and nutritional interventions in nonalcoholic fatty liver disease in pediatrics","volume":"15","author":"Far\u00edas","year":"2023","journal-title":"Nutrients"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0181095","DOI":"10.1371\/journal.pone.0181095","article-title":"Effects of a multidisciplinary weight loss intervention in overweight and obese children and adolescents: 11 years of experience","volume":"12","author":"Mameli","year":"2017","journal-title":"PLoS One"},{"key":"B52","doi-asserted-by":"publisher","first-page":"914740","DOI":"10.3389\/fendo.2022.914740","article-title":"Sarcopenic obesity in children and adolescents: a systematic review [published correction appears in front endocrinol (Lausanne)","volume":"13","author":"Zembura","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.3390\/jcm9103355","article-title":"Relative skeletal muscle mass is an important factor in non-alcoholic fatty liver disease in non-obese children and adolescents","volume":"9","author":"Kwon","year":"2020","journal-title":"J Clin Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/apt.12972","article-title":"Review article: the management of paediatric nonalcoholic fatty liver disease","volume":"40","author":"Mitchel","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.3390\/nu12113531","article-title":"Fructose, omega 3 fatty acids, and vitamin E: involvement in pediatric non-alcoholic fatty liver disease","volume":"12","author":"Alberti","year":"2020","journal-title":"Nutrients"},{"key":"B57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/14656566.2019.1702967","article-title":"Treatment of nonalcoholic fatty liver disease: from adult trials to perspectives in the management of children and adolescents","volume":"21","author":"Doulberis","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1086078","DOI":"10.3389\/fimmu.2023.1086078","article-title":"Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"Scorletti","year":"2013","journal-title":"Annu Rev Nutr"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-\u03b1 and -\u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1468788\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:29:59Z","timestamp":1745818199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1468788\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":60,"alternative-id":["10.3389\/fped.2025.1468788"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1468788","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1468788"}}